Advances in Stem Cell Research and Regenerative Medicine

Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation (HSCT) is a well-established therapeutic procedure used to restore healthy blood and immune system function in patients with hematological disorders. It involves the transplantation of hematopoietic stem cells obtained from bone marrow, peripheral blood, or umbilical cord blood. HSCT is widely used to treat leukemia, lymphoma, multiple myeloma, aplastic anemia, and inherited blood disorders. The procedure may be performed using autologous (patient-derived) or allogeneic (donor-derived) stem cells, depending on the clinical condition. Advances in donor matching, conditioning regimens, and supportive care have significantly improved transplantation outcomes and patient survival. Current research focuses on reducing complications such as graft-versus-host disease (GVHD), infection, and transplant-related toxicity. Emerging approaches, including gene-modified stem cells and personalized transplantation strategies, are expanding the therapeutic potential of HSCT. Overall, hematopoietic stem cell transplantation remains a cornerstone of regenerative medicine and advanced treatment for blood-related diseases.